Hoxton Ventures

Congrats to the Formance team announcing their new Formance Platform, a comprehensive suite of agnostic infrastructure services further extending their financial core system. This key milestone helps support their mission building and selling financial infrastructure to large enterprises and financial institutions. We're excited to see what they come up with next! https://lnkd.in/d62ywiN3

At Hoxton Ventures, our fund is premised on the idea that European founders would start and win the industry categories of tomorrow. Our latest investment, leading a $30 million seed round in CuspAI, alongside Basis Set and Lightspeed, exemplifies this. Co-founded by AI pioneer Max Welling and deep-tech commercialization expert Alyn Chad Edwards, CuspAI is leveraging generative AI, deep learning, and molecular simulation to completely change the material design process. Their platform acts like a search engine for materials, enabling the rapid generation and evaluation of novel structures with specific functionalities - and opens up huge opportunities for AI-designed materials to be used in carbon capture and storage, a critical technology for reducing greenhouse gas emissions. This industry alone is projected to be worth $4 trillion by 2050. It’s clear to us that AI has the ability to shake up how we design materials. CuspAI has assembled some of the best people in the world to do this, starting with both Chad and Max. They’ve also pulled in two of the leading figures in the AI industry, Geoffrey Hinton, sometimes described as the ‘Godfather of AI,’ who is joining Cusp’s advisory board, and Yann LeCun, Chief AI Scientist at Meta, and who posted on X about the company. Congratulations to the CuspAI team! https://lnkd.in/eq8ea_24

Great progress from the Ochre Bio team securing a multi-year data license agreement with GSK to further propel investigation into the drivers of liver disease. This partnership will allow Ochre Bio and GSK to build better AI models supporting more precise experiments to prioritise and accelerate development of medicines to address this critical condition. https://lnkd.in/eeETgHV6

Exciting news from the American Society For Mass Spectrometry (ASMS) who has announced that our portfolio company Inoviv has entered into a co-marketing agreement with Waters Corporation. This collaboration marks a significant step forward advancing targeted #proteomics and accelerating life-changing treatments. By combining their expertise, Inoviv aims to develop highly sensitive quantitative #biomarker assays using the unparalleled capabilities of Waters’ state-of-the-art Xevo TQ Absolute mass spectrometer. Stay tuned for more updates from Inoviv as they continue to drive innovation and make impactful strides in the field of proteomics - www.inoviv.com #ASMS2024

Congratulations to co-founders Jack O'Meara and Quin Wills and the whole team at Ochre Bio on securing a $1bn partnership deal with Boehringer Ingelheim to develop liver disease drugs. Liver disease is actually the 3rd largest cause of early in the UK which they are tackling head on. We are thrilled to see the progress they're making on the frontier of computational bio technology to combat this global disease. Read all about it in the Financial Times: https://lnkd.in/eSRPARNK

Recently, we had the pleasure of collaborating with Pretiosum Ventures to host a sales workshop event for our founders in the Enterprise B2B space with special guests Ryan Lieber from Snowflake and Jonathan Clarke from monday.com.  The goal was to create a safe space to discuss opportunities and challenges start-ups experience when pitching and closing Enterprise clients. Some of the key takeaways were: - In the evolving Enterprise landscape, decision-makers exhibit increased prudence when engaging with new vendors compared to the 2020-2023 period. With budgets becoming more constrained, the evaluation of potential partners is more rigorous than ever. - For startups looking to define their Ideal Customer Profile (ICP), the strategy should involve an intensely focused approach. Select a single niche—what might initially feel like an 'uncomfortably narrow' scope. Deeply immerse yourself in understanding your targeted customers by analyzing their workflows, pain points, and specific jargon. If this sector is unfamiliar, consider bringing on an advisor early in your journey, with the potential to transition them into a full-time role as you gain traction. - Regarding pilot programs, avoid offering them free of charge. Experience shows that customers tend to undervalue products they haven’t financially invested in. Instead, establish clear KPIs and metrics, and ensure that decision-makers are committed to prioritizing the project. Without their active involvement, even the most well-intentioned pilots can falter, failing to convert into paying customers. The event continued with food, drinks and more food, allowing everyone to ask open questions in a small intimate gathering, including those joining virtually all the way from Scotland to Singapore! A huge thank you again to Pretiosum Ventures and to all the founders who joined us to make this a memorable and insightful evening!

Congratulations to Darktrace on their announcement to be acquired by Thoma Bravo! At Hoxton Ventures, we were fortunate to have come across the team at Darktrace early in their journey, investing shortly after their founding in 2013. Under the strong leadership of Poppy Gustafsson and Nicole Eagan, along with the rest of the founding team of Dave Palmer, Emily Orton and Jack Stockdale, Darktrace envisioned an entirely new category in cybersecurity. It is a privilege to be one small part of their big journey and we continue to aspire to invest in teams like theirs.

Congrats to Hoxton Ventures portfolio company Ochre Bio and founders Jack O'Meara and Quin Wills on announcing their partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease. https://lnkd.in/ePFjWumn

Thrilled to be speaking at the AI [Tomorrow Summit] in Turkey 23-24 May on behalf of Hoxton Ventures with the Artificial Intelligence Policies Association (AIPA) to discuss future opportunities for those embracing these transformative technologies.

Introducing Deblock 🇫🇷 👋 👉 Purchase a Car, Pay your Rent & Receive your Salary... in Crypto 🚘 🏠 👉 IBAN, Debit Card, Instant Transfers, Withdrawals... with NO LIMITS 💳 👉 Self-Custodial Wallet - digital assets protected 🤝 Launching today in France. Next up... The 🌏 €12m round co-led by Hoxton Ventures, 20VC & Headline. And no better team in Europe to tackle this complex problem! Adriana Restrepo, Jean Meyer, Aaron B. & Mario Eguiluz Alebicto are top 0.1% operators 💥 Hear from Rob Kniaz, Kieran Hill, Dominic Wilhelm & Alex Pall on why we're so excited 👇 #Tech #Funding #Crypto #Founders #Investment